PATENT CLAIM ANALYSIS

Application Number: 16292110
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "412000"]

Abstract:
The disclosure provides compounds having formula (I), where the substituents are as defined herein. The compounds are useful for modulating the dopamine D3 receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.

Claim (Index 16):
The compound of  claim 16  having formula (IXA) or (IXB).

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15750128', '11792596', '11911035', '11991576', '15583679']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7785397599334825
- 35 USC 102 Novelty (BERT): 0.5895052526521053
- Combined Prediction Score: 0.7596363092053448
- Mean Citation Score: 378.9739
- Max Citation Score: 536.0148
- Similarity Product: 389.195728452301

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test